Meet KI –@kemijski institut. As one of GeneH’s key research pillars, KI (via @CTGCT) turns research into GMP-ready steps and safety evidence, advancing CTNNB1 & Kleefstra toward clinical readiness with EU partners.
👉 www.uc.pt/geneh/
@kemijski.bsky.social
@ctgct.bsky.social

During #CTGCTDays2025, the GENE H Conference – Gene Therapy covered genome editing, biosafety, and neuro-focused applications. UC/GeneT presented SCA3 strategies (allele-specific silencing & gene inactivation). Program& abstracts: ctgct.si/en/ctgct-day...

@kemijski.bsky.social
@ctgct.bsky.social

🧬 Your voice matters for the future of gene therapy.
Are you in academia or industry? Share your insights on barriers & opportunities in the gene therapy ecosystem.
📝 Take the survey: ls.uc.pt/index.php/27...
📆 Open until August 15

@kemijski.bsky.social
@ctgct.bsky.social

🧬 Gene therapy can change lives — and your opinion helps shape the future. Take our short survey and let us know what you think about gene therapy:
📝 EN: ls.uc.pt/index.php/12...
🇵🇹 PT: ls.uc.pt/index.php/12...
🇸🇮 SI: ls.uc.pt/index.php/12...

📅 Available until August 15

🚀 We’re launching GENEH – a 🇵🇹🇸🇮 hub accelerating access to #GeneTherapy across Europe.

🧬 From lab to patient
🏥 Cross-border collaboration
🤝 Research. Industry. Patients. Policy.

🔗 www.uc.pt/en/geneh

👥 Who benefits?
- Researchers
-Biotech & Pharma
-Policymakers
-Patients & public